Related Experiment Videos
Magnetic resonance imaging in the evaluation of clinical trials in multiple sclerosis
1Department of Medicine, University of British Columbia, Vancouver, Canada.
Annals of Neurology
|January 1, 1994
Abstract:
Magnetic resonance imaging (MRI) provides an objective method of evaluating multiple sclerosis clinical trials and is at least five times more sensitive to disease activity. In a recent clinical trial, MRI was also approximately twice as sensitive as clinical measurements to the treatment effect of a drug.